Comparison between Sodium Valproate and Fluoxetine in patient with migraine and chronic fatigue syndrome

A Comparative Study between Sodium Valproate and Fluoxetine in patient with migraine and chronic fatigue syndrome

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016062828680N1

Enrollment

Registered

2016-07-19

Start date

2014-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine. Migraine

Interventions

Intervention 1: Intervention group with Fluoxetine tab 20 mg daily. Intervention 2: Intervention group with Sodium Valproat Tan 200 mg BID.

Treatment - Drugs

Intervention group with Fluoxetine tab 20 mg daily

Intervention group with Sodium Valproat Tan 200 mg BID

Eligibility

Sex/Gender

All

Age

20 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: migraine;chronic fatigue syndrome Exclusion criteria:The incidence of drug side effects;Individual may not adhere;Individual may not complete follow up

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Intensity score of headache. Timepoint: 8 weeks. Method of measurement: VAS score.;Frequency of headache. Timepoint: 8 weeks. Method of measurement: headaches attacks per week.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdis Khazaeli

Isfahan University of Medical Sciences

A.RASTI@MDOARES.AC.IR+98 31 4274 7592

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026